Literature DB >> 25836991

Neuropeptides as lung cancer growth factors.

Terry W Moody1, Paola Moreno2, Robert T Jensen2.   

Abstract

This manuscript is written in honor of the Festschrift for Abba Kastin. I met Abba at a Society for Neuroscience meeting and learned that he was Editor-in-Chief of the Journal Peptides. I submitted manuscripts to the journal on "Neuropeptides as Growth Factors in Cancer" and subsequently was named to the Editorial Advisory Board. Over the past 30 years I have published dozens of manuscripts in Peptides and reviewed hundreds of submitted manuscripts. It was always rewarding to interact with Abba, a consummate professional. When I attended meetings in New Orleans I would sometimes go out to dinner with him at the restaurant "Commanders Palace". When I chaired the Summer Neuropeptide Conference we were honored to have him receive the Fleur Strand Award one year in Israel. I think that his biggest editorial contribution has been the "Handbook of Biologically Active Peptides." I served as a Section Editor on "Cancer/Anticancer Peptides" and again found that it was a pleasure working with him. This review focuses on the mechanisms by which bombesin-like peptides, neurotensin and vasoactive intestinal peptide regulate the growth of lung cancer. Published by Elsevier Inc.

Entities:  

Keywords:  Bombesin; Lung cancer; Neurotensin; Vasoactive intestinal peptide

Mesh:

Substances:

Year:  2015        PMID: 25836991     DOI: 10.1016/j.peptides.2015.03.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

Review 2.  Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

3.  A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.

Authors:  Paola Moreno; Samuel A Mantey; Suk H Lee; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Peptides       Date:  2018-02-02       Impact factor: 3.750

Review 4.  Neurotransmitters: emerging targets in cancer.

Authors:  Shu-Heng Jiang; Li-Peng Hu; Xu Wang; Jun Li; Zhi-Gang Zhang
Journal:  Oncogene       Date:  2019-09-16       Impact factor: 9.867

Review 5.  Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation.

Authors:  Sophie Béraud-Dufour; Chistelle Devader; Fabienne Massa; Morgane Roulot; Thierry Coppola; Jean Mazella
Journal:  Int J Mol Sci       Date:  2016-11-08       Impact factor: 5.923

Review 6.  Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Authors:  Mahjabin Khan; Tao Huang; Cheng-Yuan Lin; Jiang Wu; Bao-Min Fan; Zhao-Xiang Bian
Journal:  Oncotarget       Date:  2017-06-07

7.  AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

Authors:  Terry W Moody; Nicole Tashakkori; Samuel A Mantey; Paola Moreno; Irene Ramos-Alvarez; Marcello Leopoldo; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-21       Impact factor: 5.555

Review 8.  The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells.

Authors:  Zhengyin Gao; Weng I Lei; Leo Tsz On Lee
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

Review 9.  Neuropeptide G Protein-Coupled Receptors as Oncotargets.

Authors:  Terry W Moody; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-29       Impact factor: 5.555

Review 10.  The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review.

Authors:  Stella Nikolaou; Shengyang Qiu; Francesca Fiorentino; Constantinos Simillis; Shahnawaz Rasheed; Paris Tekkis; Christos Kontovounisios
Journal:  Cell Commun Signal       Date:  2020-04-26       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.